Klaus Friedrich Rabe (Klaus F Rabe)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Chronic Obstructive Pulmonary Disease

Smoking Cessation

Atopic Dermatitis

Top Venues

Therapeutic advances in respiratory disease

International journal of chronic obstructive pulmonary disease

Journal of asthma and allergy

This page only lists publications with an associated author ORCID identifier.

Publications

Jimmy Omony, Clemens Thölken, Azam Salimi, Kristina Laubhahn, Sabina Illi, Markus Weckmann, Ruth Grychtol, Klaus Friedrich Rabe, Dominik Thiele, Svenja Foth, Stefanie Weber, Folke Brinkmann, Matthias Volkmar Kopp, Gesine Hansen, Harald Renz, Erika von Mutius, Bianca Schaub, Chrysanthi Skevaki, null null
Urinary eosinophil-derived neurotoxin is associated with reduced lung function in pediatric asthma. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 35 (6) (2024)
Jonathan Corren, David J Jackson, Thomas B Casale, Larry Borish, Klaus Friedrich Rabe, William Walter Busse, Jorge F Maspero, Daniel J Jackson, Nadia Daizadeh, Arman Altincatal, Amr Radwan, Angela Khodzhayev, Michel Djandji, Juby A Jacob-Nara, Paul J Rowe, Yamo Deniz
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization. Journal of asthma and allergy 16 (2023)
Kathrin Kahnert, Rudolf A Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus Friedrich Rabe, Tobias Welte, Claus F Vogelmeier, Jürgen Biederer
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic advances in respiratory disease 17 (2023)
Kathrin Kahnert, Rudolf A Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus Friedrich Rabe, Tobias Welte, Claus F Vogelmeier, Jürgen Biederer
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic advances in respiratory disease 17 (2023)
Peter Alter, Cosmina Stoleriu, Kathrin Kahnert, Markus Oliver Henke, Robert Bals, Franziska C Trudzinski, Henrik Watz, Tim Speicher, Sandra Söhler, Tobias Welte, Klaus Friedrich Rabe, Emiel F M Wouters, Claus F Vogelmeier, Rudolf A Joerres
Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET. International journal of chronic obstructive pulmonary disease 18 (2023)
Klaus Friedrich Rabe, Ian Douglas Pavord, William Walter Busse, Geoffrey L Chupp, Kenji Izuhara, Arman Altincatal, Rebecca Gall, Nami Pandit-Abid, Yamo Deniz, Paul J Rowe, Juby A Jacob-Nara, Amr Radwan
Dupilumab Improves Long-term Outcomes in Patients With Uncontrolled, Moderate-to-Severe GINA-Based Type 2 Asthma, Irrespective of Allergic Status. Allergy (2023)
Jonathan Corren, David J Jackson, Thomas B Casale, Larry Borish, Klaus Friedrich Rabe, William Walter Busse, Jorge F Maspero, Daniel J Jackson, Nadia Daizadeh, Arman Altincatal, Amr Radwan, Angela Khodzhayev, Michel Djandji, Juby A Jacob-Nara, Paul J Rowe, Yamo Deniz
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization. Journal of asthma and allergy 16 (2023)
Kathrin Kahnert, Rudolf A Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus Friedrich Rabe, Tobias Welte, Claus F Vogelmeier, Jürgen Biederer
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic advances in respiratory disease 17 (2023)
Kathrin Kahnert, Rudolf A Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus Friedrich Rabe, Tobias Welte, Claus F Vogelmeier, Jürgen Biederer
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic advances in respiratory disease 17 (2023)
Kathrin Kahnert, Rudolf A Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus Friedrich Rabe, Tobias Welte, Claus F Vogelmeier, Jürgen Biederer
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic advances in respiratory disease 17 (2023)
Kathrin Kahnert, Rudolf A Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus Friedrich Rabe, Tobias Welte, Claus F Vogelmeier, Jürgen Biederer
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic advances in respiratory disease 17 (2023)
Peter Alter, Kathrin Kahnert, Franziska C Trudzinski, Robert Bals, Henrik Watz, Tim Speicher, Sandra Söhler, Tobias Welte, Klaus Friedrich Rabe, Emiel F M Wouters, Claus F Vogelmeier, Rudolf A Jörres
Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort. Therapeutic advances in respiratory disease 17 (2023)
Mona Bafadhel, Klaus Friedrich Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Martin Jenkins, Magnus Aurivillius, Mehul S Patel, Paul Dorinsky
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS. International journal of chronic obstructive pulmonary disease 17 (2022)
Mustafa Abdo, Frauke Pedersen, Frederik Trinkmann, Felix J F Herth, Klaus Friedrich Rabe, Anne-Marie Kirsten, Henrik Watz
Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD. International journal of chronic obstructive pulmonary disease 17 (2022)
Peter Alter, Kathrin Kahnert, Franziska C Trudzinski, Robert Bals, Henrik Watz, Tim Speicher, Sandra Söhler, Stefan Andreas, Tobias Welte, Klaus Friedrich Rabe, Emiel F M Wouters, Antonia Sassmann-Schweda, Hubert Wirtz, Joachim H Ficker, Claus F Vogelmeier, Rudolf A Joerres
Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET. International journal of chronic obstructive pulmonary disease 17 (2022)
Mona Bafadhel, Klaus Friedrich Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Martin Jenkins, Magnus Aurivillius, Mehul S Patel, Paul Dorinsky
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS. International journal of chronic obstructive pulmonary disease 17 (2022)
Mona Bafadhel, Klaus Friedrich Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Martin Jenkins, Magnus Aurivillius, Mehul S Patel, Paul Dorinsky
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS. International journal of chronic obstructive pulmonary disease 17 (2022)
Dave Singh, John R Hurst, Fernando J Martinez, Klaus Friedrich Rabe, Mona Bafadhel, Martin Jenkins, Domingo Salazar, Paul Dorinsky, Patrick Darken
Predictive modeling of COPD exacerbation rates using baseline risk factors. Therapeutic advances in respiratory disease 16 (2022)
Klaus Friedrich Rabe, Fernando J Martinez, Dave Singh, Roopa Trivedi, Martin Jenkins, Patrick Darken, Magnus Aurivillius, Paul Dorinsky
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial. Therapeutic advances in respiratory disease 15 (2022)
Jakob J Malin, Christoph D Spinner, Uwe Janssens, Tobias Welte, Steffen Weber-Carstens, Gereon Schälte, Petra Gastmeier, Florian Langer, Martin Wepler, Michael Westhoff, Michael Pfeifer, Klaus Friedrich Rabe, Florian Hoffmann, Bernd W Böttiger, Julia Weinmann-Menke, Alexander Kersten, Peter Berlit, Marcin Krawczyk, Wiebke Nehls, Falk Fichtner, Sven Laudi, Miriam Songa Stegemann, Nicole Skoetz, Monika Nothacker, Gernot Marx, Christian Karagiannidis, Stefan Kluge
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021). Infection (2021)
Jakob J Malin, Christoph D Spinner, Uwe Janssens, Tobias Welte, Steffen Weber-Carstens, Gereon Schälte, Petra Gastmeier, Florian Langer, Martin Wepler, Michael Westhoff, Michael Pfeifer, Klaus Friedrich Rabe, Florian Hoffmann, Bernd W Böttiger, Julia Weinmann-Menke, Alexander Kersten, Peter Berlit, Marcin Krawczyk, Wiebke Nehls, Falk Fichtner, Sven Laudi, Miriam Songa Stegemann, Nicole Skoetz, Monika Nothacker, Gernot Marx, Christian Karagiannidis, Stefan Kluge
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021). Infection (2021)